Indication and Safety Information

FLUDEOXYGLUCOSE F 18 INJECTION, USP

For Intravenous Use

 

INDICATIONS AND USAGE


Fludeoxyglucose F 18 injection (18F FDG) is indicated for positron emission tomography (PET) imaging in the following settings:

 

Oncology: For assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer.

 

Cardiology: For the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging.

 

Neurology: For the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures.

 

IMPORTANT SAFETY INFORMATION
 

Radiation Risks: Radiation-emitting products, including fludeoxyglucose F 18 injection, may increase the risk for cancer, especially in pediatric patients. Use the smallest dose necessary for imaging and ensure safe handling to protect the patient and health care worker.

 

Blood Glucose Abnormalities: In the oncology and neurology setting, suboptimal imaging may occur in patients with inadequately regulated blood glucose levels. In these patients, consider medical therapy and laboratory testing to assure at least two days of normoglycemia prior to fludeoxyglucose F18 injection administration.

 

Adverse Reactions: Hypersensitivity reactions with pruritus, edema and rash have been reported; have emergency resuscitation equipment and personnel immediately available.

SODIUM FLUORIDE F 18 INJECTION

For Intravenous Use

 

INDICATIONS AND USAGE

Sodium Fluoride F 18 Injection is a radioactive diagnostic agent for positron emission tomography (PET) indicated for imaging of bone to define areas of altered osteogenic activity.

 

IMPORTANT SAFETY INFORMATION

 

Allergic Reactions: As with any injectable drug product, allergic reactions and anaphylaxis may occur. Emergency resuscitation equipment and personnel should be immediately available.

 

Cancer Risk: Sodium Fluoride F 18 Injection may increase the risk of cancer. Use the smallest dose necessary for imaging and ensure safe handling to protect the patient and health care worker.

 

ADVERSE REACTIONS

No adverse reactions have been reported for Sodium Fluoride F 18 Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting system.

 

LOUISIANA PET/CT IMAGING

of Lake Charles, LLC

1750 Ryan Street

Lake Charles, LA 70601

 

P - 337.433.3001

F - 337.433.0540

 

Hours of Operation

8:00 am - 5:00 pm

Monday - Friday

 

 

Our Staff

Christopher King 

  President 

Ronald Weems 

  VP Field Operations 

Jeremiah Juneau 

  Technologist 

Sherry Perkins 

  Patient Care Coordinator

 

Print Print | Sitemap
© Louisiana PET/CT Imaging of Lake Charles, LLC